Chemoinformaics analysis of 2-Cyclopentylidenecyclopentanone
Molecular Weight | 150.221 | nRot | 0 |
Heavy Atom Molecular Weight | 136.109 | nRig | 12 |
Exact Molecular Weight | 150.104 | nRing | 2 |
Solubility: LogS | -2.961 | nHRing | 0 |
Solubility: LogP | 2.509 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.485 |
Synth | 2.588 |
Natural Product Likeliness | 0.664 |
NR-PPAR-gamma | 0.214 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.959 |
Pgp-sub | 0.001 |
HIA | 0.007 |
CACO-2 | -4.664 |
MDCK | 0.0000233 |
BBB | 0.883 |
PPB | 0.88482 |
VDSS | 0.619 |
FU | 0.0787142 |
CYP1A2-inh | 0.865 |
CYP1A2-sub | 0.871 |
CYP2c19-inh | 0.455 |
CYP2c19-sub | 0.209 |
CYP2c9-inh | 0.296 |
CYP2c9-sub | 0.329 |
CYP2d6-inh | 0.652 |
CYP2d6-sub | 0.283 |
CYP3a4-inh | 0.053 |
CYP3a4-sub | 0.297 |
CL | 3.685 |
T12 | 0.639 |
hERG | 0.014 |
Ames | 0.02 |
ROA | 0.085 |
SkinSen | 0.799 |
Carcinogencity | 0.779 |
EI | 0.809 |
Respiratory | 0.468 |
NR-Aromatase | 0.114 |
Antiviral | No |
Prediction | 0.93019 |